πŸ‡ΊπŸ‡Έ FDA
Patent

US 8940753

Methods for treating pruritis

granted A61KA61K31/485A61K45/06

Quick answer

US patent 8940753 (Methods for treating pruritis) held by Trevi Therapeutics, Inc. expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Trevi Therapeutics, Inc.
Grant date
Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/485, A61K45/06, A61K9/0053, A61K9/2009